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ABSTRACT 
 
Wound healing is a series of biophysiological processes, beginning with tissue injury, 
and ending with repairs from the wound tissue itself to a complete state consisting of several 
phases including inflammation, proliferation and remodeling. Every process of wound 
healing always leaves a scar. Hypertrophic and keloid is a product of abnormal wound 
healing. This abnormal scar formation is influenced by several factors, one of which is the 
wound stress. A tension that is too large in a wound will cause a hypoxic state in the wound 
itself. This hypoxic state will cause recurrent inflammation which leads to abnormal scar 
formation. One of abnormal scars formation prevention is reduction in wound tension. 
Reduction in  wound tension reduce the inflammation process. 
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Wound healing 
 Wound healing is a series of 
biophysiological processes, beginning with 
tissue injury, and end with the complete 
repair of the wound tissue itself. This wound 
healing process consists of three interrelated 
and overlapping phases including 1. 
Inflammation; 2. Proliferation; 3. Remodeling 
(1) 
 
Inflammatory Phase  
 The inflammatory phase occurs four 
days after injury. This inflammatory phase is 
described as rubor et tumor cum calore et 
dolore.(2) This inflammatory response can be 
distinguished into a vascular response and 
cellular response (3). The vascular response 
that comes out during bleeding is direct 
vasoconstriction in the blood vessels to 
minimize blood loss. Another vascular 
response is the formation of fibrin clot.(4) Pro-
inflammatory cytokines and growth factors 
such as tumour growth factor-β (TGF-β), 
platelet derived growth factors (PDGF), 
fibroblast growth factor (FGF) and epidermal 
growth factor (EGF) will be released by 
Fibrin clot and surrounding injury tissue. 
After bleeding can be controlled, 
inflammatory cells will migrate to the wound 
(chemotaxis) and continue with cellular 
response to the inflammatory phase. (1,5) This 
cellular response begins when there is an 
influx of leukocytes, neutrophils and 
monocytes in the injured area. These 
monocytes will later become macrophages. 
These neutrophils and monocytes migrate to 
the wound area because of the chemotaxic 
factor released during the vascular response 
(hemostasis) by mast cells.(3) Neutrophils 
phagocytes microorganisms in the wound and 
act as the first line of defense in preventing 
infection.(4) Macrophages have an important 
role in the process of wound healing. 
Macrophages are phagocytic monocytes that 
are responsible for recognizing foreign 
microorganisms in the body, initiating of the 
inflammatory phase, and tissue restoration.(6) 
Macrophages can be called the initial triggers 
of the proliferation phase in the wound 
healing process.(5) 
 
Proliferation Phase  
The proliferation phase occurs after 
the inflammatory phase and overlaping with 
each other. This proliferation phase occurs for 
4-21 days in acute wounds, depending on the 
size of the wound and the patient condition.(7) 
This proliferation phase is characterized by 
the initiation of angiogenesis process, tissue 
granulation formation, wound contraction, 
epithelial proliferation, and re-
epithelialization.(8) In reparative dermis 
condition during the proliferation phase, 
many cells are found such as fibroblast cells, 
pericytes keratinocytes and endothelial cells. 
In this proliferation phase, fibroblasts 
migrate. This fibroblast migration is 
influenced by the activity of factors such as 
TGF-β and PDGF, which are released by 
inflammatory cells and platelets.(9) Fibroblast 
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cells will secrete collagen which will then 
induce regeneration from the dermal. On the 
basis of the wound area, fibroblasts also 
produce glycosaminoglycans, and 
proteoglycans as the main components of 
extra cellular matrix fluids. Pericytes cells are 
responsible for regenerating the outer part of 
the capillaries, and endothelial cells. This 
process is called angiogenesis. 
 
Remodeling Phase 
The last phase of the wound healing 
process is the remodeling phase. This phase 
can continue up to several years during the 
wound healing process. The remodeling 
phase begins when extracellular matrix fluid 
has been formed.(10) Microscopic findings 
show that in this phase there is a decrease in 
the number of fibroblasts, vascular occlusion, 
and hardening of collagen fibers. The 
production and degradation of collagen that 
takes place continuously during the 
remodeling phase has a dominant effect in 
wound maturation. Production and 
degradation balance each other, and normally 
there is no major difference in the amount of 
production and degradation of collagen.(11) 
 
Pathogenesis of Abnormal Scars 
 Abnormal scarring results from 
prolongation and abnormalities in the wound 
healing process. This causes excessive 
production of fibroblasts and collagen 
deposition.(12) This excessive collagen 
deposition may occur because of three 
possibilities: 1. Increased synthesis without 
being accompanied by increased degradation; 
2. The synthesis and degradation of collagen 
both increase, but the increase in collagen 
synthesis is higher than the degradation; 3. 
Normal collagen synthesis but with decreased 
degradation. Abergel's study reported that 
keloid scar was found to accumulate collagen 
with proline hydroxylase enzyme activity 14-
20 times greater than normal scar and 3 times 
when compared with hypertrophic scarring 
and keloid collagenase activity which 
increased 14 times normal scar and 4 times 
hypertrophic scar .(13) 
 Prolonged inflammatory phase and the 
presence of an immune response during the 
wound healing process are factors in the 
formation of hypertrophic and keloid scars. 
The immune response that comes out during 
the inflammatory process, especially the 
expression of Th2 with the production of IL-
4, IL-5, IL-10, IL-13 are much associated 
with fibrogenesis, while Th1 and CD41 are 
mostly associated with fibrosis through the 
production of interferon and IL -12.(14) 
 Not only during the inflammatory 
phase, recent studies have shown the 
involvement of growth factors in hypertrophic 
and keloid scar formation during the 
fibrogenic phase.(15) When compared to 
normal fibroblasts, hypertrophic and keloid 
scar fibroblasts show an increased number of 
receptor growth factors, especially in TGF-β 
and PDGF.(16) TGF-β has the effect of 
chemotaxis on fibroblasts to the wound area. 
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TGF-β also has a role for fibroblast 
proliferation and collagen production. 
Normally, when the wound healing process is 
complete, the activity of TGF-β also 
automatically stops. However, hypertrophic 
scars and keloids occur have abnormalities in 
the autocrine signaling mechanism resulting 
in overproduction and poor regulation of 
TGF-β (Figure 1). Transforming growth 
factor-β1 (TGFβ1) and TGFβ2 are the most 
important stimulators of collagen and 
proteoglycan synthesis and affect 
extracellular matrix fluid, not only by 
stimulating collagen production but also 
preventing destruction. On the other hand, 
TGFβ3 has a function that is opposite to 
TGFβ1 and TGFβ2, which is reducing 
connective tissue deposition. Studies also 
show that in hypertrophic and keloid scarring, 
over-expressions of TGFβ1 and TGFβ2 are 
found followed by decreased expression of 
TGFβ3.(17,18,19) 
 
 
Figure 1. Schema of the Abnormal Scar Process: A. Normal Wound Healing, B. Excessive 
Scaring(20) 
Wound Tension and Scar Quality 
The concept of tension on the skin has 
been introduced more or less 200 years ago. 
Human body consists of a skeletal bone, 
which is covered by the skin. This covering 
skin must be elastic, so that it can return to its 
original shape when stretching during 
activity. Mechanically, the skin must be 
strong and flexible.(21,22) Tension on the skin, 
depending on the movement of the skeleton 
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below, and the high tension of the skin in 
certain anatomical regions are often 
associated with abnormal scarring. Langer’s 
line is best known to clinicians in determining 
the skin tension lines of the human body 
(Figure 2).(23) The stress lines on this skin 
follow collagen collections that are present in 
the dermis. Parts of the skin with a high skin 
tension include the chest, shoulders, extremity 
region, and face. There are also parts of the 
skin that do not have high tension, which is 
often referred to as the relaxed skin tension 
line (RSTL). This line is commonly used by 
clinicians to make excision and incision on 
the skin to reduce the chance of abnormal 
scarring(24) 
 
Figure 2. Langer Line and Resting Static Tension Line (22) 
 One factor of the occurrence of 
abnormal scarring is delayed wound healing 
caused by prolonged inflammation.(25) 
Inflammation that is higher in the wound area 
results in greater tension as well, this causes 
blood vessel overgrowth, nerve overgrowth, 
cell proliferation and matrix hyperproduction 
(Figure 3). Direct reduction of stress on the 
wound will also increase the supply of 
oxygen to the wound and accelerate the 
wound healing process(26). The absence of 
adequate oxygen supply will make the wound 
hypoxic. This hypoxic condition will 
stimulate the body to release HIF-1 as a 
compensation mechanism. This HIF-1 can 
induce inflammatory processes and 
angiogenic processes. HIF-1 affect the 
inflammatory response by changing 
metabolic functions to glycolysis. (HIF-1) 
also has a function as a regulator of 
macrophage activity during the inflammatory 
process. HIF-1 has an important function in 
the differentiation of myeloid cells into 
monocytes and macrophages.(27) HIF-1 also 
has a stimulus effect in the process of 
angiogenesis. HIF-1 has an effect on 
increasing VEGF expression which is a 
potent angiogenic factor during the 
angiogenesis process.(28) The aim of stress 
reduction is to prevent of overexpression of 
this HIF-1. 
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Figure 3. Skin Tension Schematic and the Abnormal Scratch (24) 
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